Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome

Gastroenterology Insights, Free Full-Text

Symptomatic assessment tools. The figure collects the different tools

JCM, Free Full-Text

Gastrointestinal Neuroendocrine Tumors and the Carcinoid Syndrome - Endotext - NCBI Bookshelf

Vitamins

Mean change from baseline in stool form at six weeks for patients

Efficacy, safety and unmet needs of evolving medical treatments for carcinoid syndrome - Koumarianou - 2022 - Journal of Neuroendocrinology - Wiley Online Library

Targeted Systemic Treatment of Neuroendocrine Tumors: Current

Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome, Journal of Patient-Reported Outcomes